Philips Launches AI-Powered SmartSpeed Precise MRI Software at ECR
The updated software reportedly enables a threefold improvement in MRI scan time and enhanced image sharpness.
Philips has unveiled SmartSpeed Precise, an artificial intelligence (AI) software that may significantly bolster scan times and image sharpness with MRI scans.
Launched at the European Congress of Radiology (ECR) conference, the SmartSpeed Precise software allows up to a threefold reduction in MRI scan times, according to Philips.
Here one can see a pelvic MRI with use of the SmartSpeed Precise technology on a Philips Ingenia Evolution MR 3T scanner. The SmartSpeed Precise software, which is being launched at the European Congress of Radiology (ECR) conference, reportedly facilitates an 80 percent improvement in image sharpness on MRI. (Image courtesy of Philips.)
Incorporating the company’s Compressed SENSE and SmartSpeed technologies, Philips said the next-generation SmartSpeed Precise software facilitates detection of subtle abnormalities with an 80 percent improvement in image sharpness.
“We are impressed by the extremely sharp and crisp images, diagnostic confidence, and fast scans delivered by the dual-AI SmartSpeed Precise solution. We expect it will set a new standard in clinical performance with its ease of use, high image quality, and acceleration controlled by a single parameter,” noted Wayne Picker, a vice president of clinical technology at Prenuvo, Inc.
Possible Real-Time Adaptive Approach to Breast MRI Suggests ‘New Era’ of AI-Directed MRI
June 3rd 2025Assessing the simulated use of AI-generated suspicion scores for determining whether one should continue with full MRI or shift to an abbreviated MRI, the authors of a new study noted comparable sensitivity, specificity, and positive predictive value for biopsies between the MRI approaches.
Can AI Assessment of PET Imaging Predict Treatment Outcomes for Patients with Lymphoma?
June 2nd 2025The use of adjunctive AI software with pre-treatment PET imaging demonstrated over a fourfold higher likelihood of predicting progression-free survival (PFS) in patients being treated for lymphoma, according to a new meta-analysis.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.
